2006
DOI: 10.1097/01.ta.0000219013.64168.b2
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Fresh Whole Blood in Massive Transfusion

Abstract: Under extreme and austere circumstances, the risk:benefit ratio of whole blood transfusion favors its use. Fresh whole blood may, at times, be advantageous even when conventional component therapy is available.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
182
1
2

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 197 publications
(186 citation statements)
references
References 49 publications
1
182
1
2
Order By: Relevance
“…36 The indications for the use of plasma have been determined by estimates of plasma protein requirements based on calculation, animal studies, and clinical experience during the time when stored whole blood was primarily transfused. 37 Standard indications for the use of plasma have included either a 1 to 2 blood volume loss or an INR greater than 1.5 times above normal in a patient with active bleeding.…”
Section: Discussionmentioning
confidence: 99%
“…36 The indications for the use of plasma have been determined by estimates of plasma protein requirements based on calculation, animal studies, and clinical experience during the time when stored whole blood was primarily transfused. 37 Standard indications for the use of plasma have included either a 1 to 2 blood volume loss or an INR greater than 1.5 times above normal in a patient with active bleeding.…”
Section: Discussionmentioning
confidence: 99%
“…8 When the fractionation of blood products was developed around World War II, treatment with BCT became the standard primarily because of the ease of storage and the ability to elicit specific effects (eg, packed red cells for low hematocrit). 9 This change to component therapy occurred without robust research aimed at comparing health outcomes between FWB and BCT. 9,10 Additionally, guidelines from the Food and Drug Administration regarding blood storage are based on red blood cell (RBC) membrane integrity and adenosine triphosphate levels within the cell and not on oxygen delivery to the tissues.…”
Section: Hemorrhage Transfusion Practicesmentioning
confidence: 99%
“…9 This change to component therapy occurred without robust research aimed at comparing health outcomes between FWB and BCT. 9,10 Additionally, guidelines from the Food and Drug Administration regarding blood storage are based on red blood cell (RBC) membrane integrity and adenosine triphosphate levels within the cell and not on oxygen delivery to the tissues. 11 These concerns regarding the safety and effectiveness of transfusing older blood products as well as the lack of clinical outcomes to demonstrate the superiority or even equivalence of BCT to whole blood has resulted in a renewed interest in FWB therapy.…”
Section: Hemorrhage Transfusion Practicesmentioning
confidence: 99%
See 1 more Smart Citation
“…[6] Massive transfusion may increase risk of hemorrhage due to presence of anticoagulants and high levels of preservative solutions, which may lead to dilutional coagulopathy within the first 24 hours. [7] WFWB has the several advantages. Risk of hypothermia is reduced, oxygen delivery capacity is maintained in RBCs, and platelets and coagulation factors can be preserved for up to 72 hours.…”
Section: Discussionmentioning
confidence: 99%